Jump to content

Metabutoxycaine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 79.71.64.119 (talk) at 16:22, 28 October 2022 (patent). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Metabutoxycaine
Clinical data
Routes of
administration
Dental syringe (as novocaine is administered)
Pharmacokinetic data
MetabolismLasts for at least 12 hours after injection.
Identifiers
  • 2-diethylaminoethyl 3-amino-2-butoxybenzoate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H28N2O3
Molar mass308.422 g·mol−1
3D model (JSmol)
  • CCCCOC1=C(C=CC=C1N)C(=O)OCCN(CC)CC
  • InChI=1S/C17H28N2O3/c1-4-7-12-21-16-14(9-8-10-15(16)18)17(20)22-13-11-19(5-2)6-3/h8-10H,4-7,11-13,18H2,1-3H3
  • Key:LJQWYEFHNLTPBZ-UHFFFAOYSA-N
  (verify)

Metabutoxycaine, marketed under the trade name Primacaine, is a local anesthetic. It is used in dentistry.[1]

Patent:[2]

References

  1. ^ Wang HS, Gao MS, Li S (December 2003). "[Application of primacaine in operative dentistry: analysis of clinical results]". Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology (in Chinese). 12 (6): 452, 459. PMID 14966589.
  2. ^ Raymond O Clinton, Stanley C Laskowski, U.S. patent 2,882,296 (1959 to Sterling Drug Inc).